< Back to companies
310.ai
San Francisco, California, United States
Design of novel biomolecules is the single most impactful advancement that will be enabled by AI in the coming decade. 310 is building the AI engine that delivers this reality.
Company Info
- Founded
- 2022
- Website
- 310.ai:443/
Categories
AI drug discoveryDrug DiscoveryBiotechAI / ML
Disease Areas
Technologies
AI/Machine LearningAI-driven Drug DiscoveryMolecular DesignProtein Design
Only accessible to MedStartr community members. Join now
Only accessible to MedStartr community members.
Join nowWhat do you think of 310.ai?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.